Clinical trials: See for trials with mek inhibitor. http://clinicaltrials.gov/ct2/results?term=lung+cancer+k+ras+mutation&pg=3 one of them selumetinib shows a promising result in advanced stage of adenoca with kras mutation. http://www.medscape.com/viewarticle/779075.
Answered 4/21/2013
5.2k views
No: Treatment of stage 4 nsclc is chemotherapy/ radiation therapy. Surgery is no an option unless it is for symptom control (bleeding). Immunotherapy, radiofrequency ablation, cryoablation, and other therapies are being tested and utilized, but if the primary therapies are no longer in use, then supportive care should be considered.
Answered 12/16/2014
5.1k views
3 doctors weighed in across 2 answers
3 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
3 doctors weighed in across 3 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question